AFP and hepatocellular carcinoma: Through the administration of direct-acting antiviral therapy to over 2 million individuals, the program has been instrumental in identifying numerous HCC cases during follow-up surveillance using ultrasound and Alpha fetoprotein (AFP) testing6,7.